Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	66,766	36,883	25,545	23,695	21,747	18,638
Market Cap Growth	73.06%	44.38%	7.81%	8.96%	16.68%	-14.41%
Enterprise Value	67,680	37,658	26,256	25,227	22,521	19,066
Last Close Price	60.19	33.00	22.72	21.84	19.79	16.76
PE Ratio	220.10	93.27	86.56	85.52	63.02	29.28
Forward PE	127.16	58.20	60.57	69.53	62.77	23.76
PS Ratio	15.64	9.91	7.61	7.86	7.84	5.60
PB Ratio	15.80	8.78	6.13	7.56	7.45	6.53
P/TBV Ratio	25.01	12.56	7.45	10.18	10.07	8.10
P/FCF Ratio	293.77	26513.20	436.15	-	-	-
P/OCF Ratio	105.10	83.44	56.82	250.62	607.43	90.39
EV/Sales Ratio	15.85	10.12	7.83	8.37	8.12	5.73
EV/EBITDA Ratio	139.22	75.57	48.24	79.50	122.44	57.27
EV/EBIT Ratio	-	143.72	79.19	178.20	598.98	83.50
EV/FCF Ratio	297.79	27070.49	448.29	-	-	-
Debt / Equity Ratio	0.55	0.46	0.43	0.67	0.43	0.38
Debt / EBITDA Ratio	4.77	3.76	3.28	6.48	6.55	3.23
Debt / FCF Ratio	10.21	1373.28	30.84	-	-	-
Asset Turnover	0.61	0.55	0.53	0.55	0.56	0.66
Inventory Turnover	4.10	3.84	3.10	3.05	3.91	5.17
Quick Ratio	1.57	1.48	1.50	1.09	0.81	1.04
Current Ratio	1.76	1.74	1.76	1.38	1.02	1.22
Return on Equity (ROE)	7.36%	11.14%	8.09%	12.94%	17.93%	22.98%
Return on Assets (ROA)	1.97%	2.44%	3.26%	1.60%	0.47%	2.84%
Return on Capital (ROIC)	2.18%	2.71%	3.69%	1.88%	0.58%	3.86%
Return on Capital Employed (ROCE)	4.10%	5.00%	6.40%	3.10%	1.10%	7.00%
Earnings Yield	0.46%	1.07%	1.16%	1.17%	1.59%	3.42%
FCF Yield	0.34%	0.00%	0.23%	-2.56%	-3.07%	-2.12%
Dividend Yield	0.69%	1.26%	0.88%	-	0.94%	2.22%
Payout Ratio	108.47%	106.72%	14.43%	89.32%	123.52%	20.54%
Buyback Yield / Dilution	-2.50%	-3.37%	-2.57%	1.17%	0.07%	-0.50%
Total Shareholder Return	-1.82%	-2.11%	-1.69%	1.17%	1.00%	1.72%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.